Elham Rismani
Impact in
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Wnt/β-catenin signaling in development and cancer 3
- Pluripotent Stem Cells Research 3
- Cancer-related gene regulation 3
- RNA modifications and cancer 3
-
- Toxin Mechanisms and Immunotoxins 3
- Co-authors
- Behrooz Johari (7 shared papers)Mehdi Kadivar (3 shared papers)Yousef Mortazavi (2 shared papers)Ali Sharafi (2 shared papers)Mahmoud Gharbavi (2 shared papers)Ladan Teimoori‐Toolabi (3 shared papers)Navid Mousazadeh (1 shared paper)Amir Hossein Taromchi (1 shared paper)
- Journals
- Journal of Biomolecular Structure and Dynamics (4 papers)Cell Biology International (3 papers)Scientific Reports (2 papers)Journal of Cellular Physiology (2 papers)Journal of Molecular Graphics and Modelling (2 papers)
- Partner nations
- IranSwedenUnited States
In The Last Decade
Elham Rismani
34 papers receiving 323 citations
Peers
Comparison fields: 5 of 76
- Biomaterials 61
- Pharmaceutical Science 16
- Molecular Biology 175
- Molecular Medicine 12
- Cancer Research 28
Countries citing papers authored by Elham Rismani
This map shows the geographic impact of Elham Rismani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Rismani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Rismani more than expected).
Fields of papers citing papers by Elham Rismani
This network shows the impact of papers produced by Elham Rismani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Rismani. The network helps show where Elham Rismani may publish in the future.
Co-authors
The 25 scholars most cited alongside Elham Rismani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 43 | |
| 2 | 2020 | 34 | |
| 3 | 2020 | 32 | |
| 4 | Optimization of the expression of reteplase in Escherichia coli. | 2011 | 24 |
| 5 | 2017 | 23 | |
| 6 | 2021 | 15 | |
| 7 | 2023 | 15 | |
| 8 | 2006 | 15 | |
| 9 | 2020 | 15 | |
| 10 | 2017 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2019 | 8 | |
| 15 | 2024 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2025 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2023 | 3 |
About Elham Rismani
Elham Rismani is a scholar working on Molecular Biology, Immunology, Oncology, Genetics and Biotechnology, having authored 39 papers that have together received 328 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Pluripotent Stem Cells Research (3 papers), Cancer-related gene regulation (3 papers), RNA modifications and cancer (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Biomaterials (61 citations), Pharmaceutical Science (16 citations), Molecular Biology (175 citations), Molecular Medicine (12 citations) and Cancer Research (28 citations). Elham Rismani has collaborated with scholars based in Iran, Sweden and United States. Frequent co-authors include Behrooz Johari, Mehdi Kadivar, Yousef Mortazavi, Ali Sharafi, Mahmoud Gharbavi, Ladan Teimoori‐Toolabi, Navid Mousazadeh, Amir Hossein Taromchi, Hamzeh Rahimi and Kayhan Azadmanesh. Their work appears in journals such as Journal of Biomolecular Structure and Dynamics, Cell Biology International, Scientific Reports, Journal of Cellular Physiology and Journal of Molecular Graphics and Modelling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.